| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |